Unusual inclusions in cerebrospinal fluid macrophages of spinal muscular atrophy patients treated with nusinersen

Int J Lab Hematol. 2021 Jun;43(3):e104-e106. doi: 10.1111/ijlh.13392. Epub 2020 Nov 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers
  • Disease Management
  • Histocytochemistry / methods
  • Humans
  • Inclusion Bodies / pathology*
  • Liquid Biopsy
  • Macrophages / pathology*
  • Muscular Atrophy, Spinal / cerebrospinal fluid
  • Muscular Atrophy, Spinal / diagnosis*
  • Muscular Atrophy, Spinal / therapy*
  • Oligonucleotides / administration & dosage
  • Oligonucleotides / therapeutic use*
  • Treatment Outcome

Substances

  • Biomarkers
  • Oligonucleotides
  • nusinersen